Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
COMPOSITIONS COMPRISING NEISSERIA MENINGITIDIS ANTIGENS FROM SEROGROUPS B AND C AS WELL AS A FURTHER ANTIGEN
No-Receipt date
2009-01993 - 03/06/2009
No-Filing date
20090401448 - 03/06/2009
No-Granting date
3069165 - 04/06/2009
No-EPO application date
00981554.9 - 29/11/2000
No-EPO granting date
1235589 - 08/04/2009
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2009 - 13/07/2009
Expiration date
30/11/2020
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
GB992819629/11/1999/GB
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 39/095
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
683342
GLAXOSMITHKLINE BIOLOGICALS S.A.
RUE DE L`INSTITUT, 89
1330 RIXENSART, BELGIUM
BELGIUM
Inventors
Code
Firstname
Surname
665495
GIULIANI, MARZIA, MONICA
665496
PIZZA, MARIAGRAZIA
665497
RAPPUOLI, RINO
Representatives
Code
Firstname
Surname
Address
Town
Zip
742
KONSTANTINOS
KILIMIRIS
XATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2119
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
18/09/2017
Μεταβίβαση (7e802)
Α.Π.3992-Η.Θ.9166/18-7-17,ΔΝΥ1186,ΚΩΔ.ΠΛΗΡ.3190
282955 Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina 1 ΙΤΑΛΙΑ 53100 Siena (SI)
683342 GlaxoSmithKline Biologicals S.A. Rue de l`Institut, 89 ΒΕΛΓΙΟ 1330 Rixensart, BELGIUM
Title Instruments
Date
Operation
Descreption
6/4/2018 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 05/2018 Αρ. Πρωτ. ΓΔ 1313 / 04-06-2018
Payments history
17 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).